Skip to Main Content
TRC_PLH
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Diabetes Drugs
    • Do Not Crush List
    • IV Fluid Safety
    • New Drugs
    • Opioid Dosing
    • Vancomycin Dosing
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

NatMed Pro, the largest natural medicines database, just got a major upgrade! With faster performance, a redesigned interface, and improved navigation, it's easier than ever to find the evidence-based answer you need. Explore Now
Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Hospital Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Cardiology
  4. Ischemic Heart Disease/Acute Coronary Syndromes
  5. Treatment
  6. Prasugrel (Effient)

Prasugrel (Effient)

  • Angina (18)
  • Antithrombotics (289)
  • Arrhythmias (131)
  • Blood Pressure (33)
  • Cardiovascular Disease and Depression (6)
  • Cholesterol (23)
  • CPR (6)
  • Dyslipidemia (168)
  • Endocarditis (21)
  • Heart Disease (84)
  • Heart Failure (155)
  • Hypertension (225)
  • Hypotension (27)
  • Ischemic Heart Disease/Acute Coronary Syndromes (244)
    • Cardiovascular Markers (27)
    • Drug-Induced Ischemic Heart Disease (17)
    • Guidelines (1)
    • Prevention (62)
    • Treatment (188)
      • ACEIs (39)
      • Anticoagulants (27)
      • ARBs (38)
      • ARNIs (6)
      • Aspirin (50)
      • Beta-Blockers (49)
      • Calcium Channel Blockers (16)
      • Cangrelor (Kengreal) (2)
      • Clopidogrel (Plavix) (24)
      • Natural Medicines/Supplements (2)
      • Nitrates (17)
      • Prasugrel (Effient) (18)
      • Statins (38)
  • Myocardial Infarction (48)
  • Peripheral Vascular Disease (8)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (2)
  • Resources (699)
  • Stroke (119)
1 - 15 of 18 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Clarify Dual Antiplatelet Guidance After Stents for ACS April 2025
Chart: Dual Antiplatelet Therapy for Coronary Artery Disease March 2025
Chart: Drug Interactions: Cytochrome P450 (CYP), P-glycoprotein, and More
May 2024
FAQ: Combination Antithrombotic Therapy
April 2024
Article: Help Optimize Antithrombotic Regimens With a Coronary Stent November 2023
Article: Tailor DAPT Duration for Patients at High Bleeding Risk June 2023
Chart: Comparison of Oral Anticoagulants March 2023
Chart: Comparison of Proton Pump Inhibitors March 2022
Article: Individualize Duration of Dual Antiplatelet Therapy in Stent Patients February 2022
Article: Suggest Clopidogrel Plus Aspirin in Most ACS Patients After a Coronary Stent November 2017
Chart: Comparison of Oral Antiplatelets November 2017
Commentary: New Drug: Kengreal (Cangrelor) October 2015
Article: Expect More Bleeding When Cangrelor Is Used September 2015
Commentary: Proton Pump Inhibitor and Plavix Interaction: An Update June 2013
Commentary: Antiplatelets After Acute Coronary Syndrome or Coronary Stent May 2012
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved